Goetz Kathleen — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Goetz Kathleen has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Kathleen Goetz is listed as a director of Aurinia Pharmaceuticals Inc. in SEC filings as of June 8, 2026. Based on the provided context, her public biographical information appears limited beyond her governance role at Aurinia. No additional publicly documented positions or prior career details are available in the given SEC context.

Board memberships

• Aurinia Pharmaceuticals Inc.

Awards & honors

• Serves on the board of directors of Aurinia Pharmaceuticals Inc. as of 2026-06-08.

Companies — Last 90 Days

• Aurinia Pharmaceuticals Inc. (AUPH) — 1 filings, last 2026-06-08

Frequently Asked Questions

Who is Goetz Kathleen?

Kathleen Goetz is listed as a director of Aurinia Pharmaceuticals Inc. in SEC filings as of June 8, 2026. Based on the provided context, her public biographical information appears limited beyond her governance role at Aurinia. No additional publicly documented positions or prior career details are available in the given SEC context.…

How many SEC Form 4 filings has Goetz Kathleen submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Goetz Kathleen's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week